Lattice Automation

Executive Summary

Lattice Automation is a Boston-based software development studio focused on the life sciences, particularly synthetic biology and AI/ML. Founded in 2016, the company serves as a deep technical partner for biotech firms, building custom software, tools, and data systems that accelerate research and development. By handling complex engineering needs, Lattice enables biotech teams to focus on scientific discovery. The company's expertise bridges the gap between cutting-edge computational methods and biological experimentation, positioning it as a key enabler in the growing synthetic biology market. With a model that combines software development with domain-specific knowledge, Lattice Automation has carved a niche in a high-demand sector. As biotech companies increasingly rely on data-driven approaches and automation, Lattice's services are becoming more critical. While the company is private and not highly publicized, its partnerships with leading biotech organizations suggest steady growth. The increasing integration of AI in drug discovery and synthetic biology bodes well for Lattice's future, though specific financial details remain undisclosed.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major Biotech Partnership60% success
• Q4 2026Launch of AI/ML Platform for Synthetic Biology40% success
• Q2 2026Series A Funding Round50% success